What is Arrowhead Research's stock issuance proceeds?

Arrowhead Research (ARWR) reported stock issuance proceeds of $46.83M in Q4 2025.

What does stock issuance proceeds mean?

Cash received from selling company stock.

How do you interpret stock issuance proceeds?

An increase suggests successful capital raising or employee participation in equity plans, while a decrease may indicate reduced reliance on equity financing.

How does stock issuance proceeds compare across companies?

Common in biotech firms to fund long-term clinical trials; peers often show periodic spikes during secondary offerings.

Arrowhead Research ARWR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Ionis PharmaceuticalsIONS

$57.3M+2,457%

BridgeBio PharmaBBIO

$22.59M—

RevvityRVTY

$5.44M+107%

Neurocrine BiosciencesNBIX

$23.6M-26.5%

ALN

Alnylam PharmaceuticalsALNY

——

Madrigal Pharmaceuticals, Inc.MDGL

——

Other financials

Income statement

See full

Revenue$73.7M-86.4%

Operating income-$141.3M-137%

Net income-$132.7M-136%

EPS (diluted)-$0.93-134%

Balance sheet

See full

Cash & equivalents$188.5M+1.5%

Total debt$107.9M-5.6%

Total equity$614.0M-10.1%

Total assets$2.3B+44.2%

Cash flow

See full

Operating cash flow$84.4M-81.6%

CapEx$2.6M-51.6%

Free cash flow$81.9M-82.0%

Valuation

See full

Market cap$11.52B+402%

Enterprise value$11.44B+418%

P/S18.5×+14.3×

Profitability

See full

Operating margin-35.7%+63.6pp

Net margin-48.4%+240pp

FCF margin1.8%+0.9pp

Returns & leverage

See full

Return on equity-46.4%+341pp

Debt / equity0.2×0.0×

Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Arrowhead Research’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arrowhead Research's stock issuance proceeds?: Arrowhead Research (ARWR) reported stock issuance proceeds of $46.83M in Q4 2025.
What does stock issuance proceeds mean?: Cash received from selling company stock.
How do you interpret stock issuance proceeds?: An increase suggests successful capital raising or employee participation in equity plans, while a decrease may indicate reduced reliance on equity financing.
How does stock issuance proceeds compare across companies?: Common in biotech firms to fund long-term clinical trials; peers often show periodic spikes during secondary offerings.